Literature DB >> 723183

[Erythropoietin in serum and urine in healthy persons and patients with chronic renal disease upon hypoxic stimulation and hypoxic stimulation after pretreatment with fluoxymesterone (author's transl)].

E Schulz, H A Dickmans, D Heesen.   

Abstract

The question of a latent erythropoietin (ESF)-deficiency was studied in incipient renal anemia using a double stimulation technique for ESF. After a 4-week stimulation of ESF production with oral administration of fluoxymesterone (flu) intermittent hypoxic ESF stimulation was performed corresponding to a maximum altitude of 4000 m in 7 patients with chronic renal disease without or with incipient renal anemia (mean hematocrit 40%) and in 11 normal subjects (mean hematocrit 46%). Double stimulation in patients was compared with hypoxic stimulation alone and both were compared with controls. After flu alone only ESF excretion was increased in patients and in normal subjects. After flu plus 10 h of hypoxia serum ESF--titers were higher in healthy subjects than in the patients. The mean ESF titer after double stimulation was 81 mU/ml in patients and 115 mU/ml in normal persons. Forty-eight hour ESF excretion was 11 U and 43 U respectively. Compared to hypoxic stimulation alone double stimulation increased serum ESF titers in patients by 5% versus 80% in controls. Correspondingly, ESF excretion was enhanced by 19% and 49%, respectively. Finally, renal ESF clearance was increased by 42% versus 200%. After hypoxia alone non-anemic patients had higher serum ESF titers than healthy controls excluding a latent ESF deficiency in incipient renal anemia. It is concluded that decreased ESF production after double stimulation in patients was due to a nephrotoxic effect of flu followed by a decreased excretory and ESF-producing function of the damaged kidneys.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 723183     DOI: 10.1007/bf01476667

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  10 in total

1.  [Erythropoietin in serum and urine in man upon hypoxic stimulation and hypoxic stimulation after pretreatment with fluoxymesterone (author's transl)].

Authors:  E Schulz
Journal:  Blut       Date:  1977-08-29

2.  A role of the kidney in the catabolism of erythropoietin in the rat.

Authors:  J P Naets; M Wittek
Journal:  J Lab Clin Med       Date:  1974-07

3.  Clinical effects of oral fluoxymesterone in patients with dialysis-controlled uremia.

Authors:  D D Lindholm; J W Fisher; J A Vieira; D H Dombeck; G Bernal; J Lerthora
Journal:  Trans Am Soc Artif Intern Organs       Date:  1973

4.  pH effect on erythropoietin response to hypoxia.

Authors:  M E Miller; M Rorth; H H Parving; D Howard; I Reddington; C R Valeri; F Stohlman
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

5.  Renal erythropoietin excretion as a function of acid base balance.

Authors:  D Marver; C W Gurney
Journal:  Ann N Y Acad Sci       Date:  1968-03-29       Impact factor: 5.691

6.  [Rise in serum creatinine under the androgen fluoxymesterone in chronic renal disease (author's transl)].

Authors:  E Schulz; G Heinecke
Journal:  MMW Munch Med Wochenschr       Date:  1976-11-26

7.  Erythropoietin excretion in man following androgens.

Authors:  R Alexanian; W K Vaughn; M W Ruchelman
Journal:  J Lab Clin Med       Date:  1967-11

8.  [Excretion of erythropoietin by humans during the production of alkaline or acidic urine (author's transl)].

Authors:  H Cissée; V E Schultz
Journal:  J Clin Chem Clin Biochem       Date:  1976-12

9.  [Comparative experiments on erythropoietin concentrations in ultrafiltered urine (Diaflo-process) and urine dialysis with higher osmolar substances (Carbowax( (author's transl)].

Authors:  E Schulz; H Cissée
Journal:  J Clin Chem Clin Biochem       Date:  1976-11

10.  Investigations on latent erythropoietin (ESF) deficiency in non anemic patients with chronic renal disease using hypoxic stimulation methods.

Authors:  E Schulz; K Finke
Journal:  Klin Wochenschr       Date:  1978-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.